Patient reported dose adequacy in injectable opioid agonist treatment: the role of patient involvement in dose decision-making

患者报告的注射阿片受体激动剂治疗剂量充足性：患者参与在剂量决策中的作用

• 批准号: 406588
• 负责人: Beaumont Scott
• 金额: $ 1.27万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-12-01 至 2019-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=406588&lang=en
• 关键词: Addictions; Dose Adequacy; Health Care Delivery; Injectable Opioid Agonist Treatment; Opioid Agonist Treatment; Opioid Use Disorder; Patient-Centered Care; Patient-Reported Measures; Quantitative Methods; Shared Decision-Making

Opioid use disorder (OUD) is a chronic condition where people sometimes continue using opioids despite negative consequences and potential risks, other times they might: engage into treatment, temporarily or permanently stop use (without treatment), or re

阿片类药物使用障碍(OUD)是一种慢性疾病，人们有时不顾负面后果和潜在风险继续使用阿片类药物，有时他们可能：进行治疗，暂时或永久停止使用(未治疗)，或重新使用